BRISBANE, Calif., Aug. 18, 2017 -- Cutera, Inc. (Nasdaq:CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, announced that Jerry P. Widman notified the Board of Directors of the Company that he intended to retire from the Board effective immediately. Mr. Widman cited age, service longevity and personal reasons for his decision.
Commented Mr. Widman, “The time has come for me to step aside and resign my Board seat at Cutera. I am fortunate to have served since 2004, and have enjoyed every minute of it. In my over 40 years of board experience, after having been a CFO for Ascension Health, Cutera is by far the most enjoyable and effective Board on which I have served. There’s never a perfect time to step aside, but at 75 years old, having served on the Board since 2004, and having several personal, family matters that require my full-time attention, this is the right move for me. The Company is well positioned to go forward and I completely support the efforts of both management and the Board without qualification.”
Mr. Widman served as the Board’s Audit Committee Chairman, as well as a member of the Compensation Committee. The Nominating & Governance committee is evaluating director candidates to replace Mr. Widman, as well as reviewing the Board’s various committees and their composition in light of Mr. Widman’s announcement.
“On behalf of all of my colleagues, I thank Jerry for his many years of valuable service to Cutera,” commented J. Daniel Plants, Cutera’s Chairman. “His financial acumen and expertise played a large part in Cutera’s success – both past and present. Moreover, Jerry’s commitment, professionalism and class have served as a great example of what shareholders should expect from their directors. Jerry will be missed, and we wish him the very best in his retirement from Cutera’s Board.”
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACTS: Cutera, Inc. Sandra A. Gardiner Chief Financial Officer (Consulting) 415-657-5500 Investor Relations John Mills ICR, Inc. 646-277-1254 [email protected]


NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Tesla Launches New Model Y Variant in the US Starting at $41,990
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 



